Literature DB >> 9592397

Controlled proliferation by multigene metabolic engineering enhances the productivity of Chinese hamster ovary cells.

M Fussenegger1, S Schlatter, D Dätwyler, X Mazur, J E Bailey.   

Abstract

The eukaryotic cell cycle is regulated by a complex network of many proteins. Effective reprogramming of this complex regulatory apparatus to achieve bioprocess goals, such as cessation of proliferation at high cell density to allow an extended period of high production, can require coordinated manipulation of multiple genes. Previous efforts to establish inducible cell-cycle arrest of Chinese hamster ovary (CHO) cells by regulated expression of the cyclin-dependent kinase inhibitor (CDI) p21 failed. By tetracycline-regulated coexpression of p21 and the differentiation factor CCAAT/enhancer-binding protein alpha (which both stabilizes and induces p21), we have achieved effective cell-cycle arrest. Production of a model heterologous protein (secreted alkaline phosphatase; SEAP) has been increased 10-15 times, on a per cell basis, relative to an isogenic control cell line. Because activation of apoptosis response is a possible complication in a proliferation-arrested culture, the survival gene bcl-xL was coexpressed with another CDI, p27, found to enable CHO cell-cycle arrest predominantly in G1 phase. CHO cells stably transfected with a tricistronic construct containing the genes for these proteins and for SEAP showed 30-fold higher SEAP expression than controls.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9592397     DOI: 10.1038/nbt0598-468

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


  42 in total

1.  Pharmacological-based translational induction of transgene expression in mammalian cells.

Authors:  Christel Boutonnet; Olivier Boijoux; Sandra Bernat; Abdelhakkim Kharrat; Gilles Favre; Jean-Charles Faye; Stéphan Vagner
Journal:  EMBO Rep       Date:  2004-06-11       Impact factor: 8.807

2.  A tunable synthetic mammalian oscillator.

Authors:  Marcel Tigges; Tatiana T Marquez-Lago; Jörg Stelling; Martin Fussenegger
Journal:  Nature       Date:  2009-01-15       Impact factor: 49.962

3.  Proteomic profiling of recombinant cells from large-scale mammalian cell culture processes.

Authors:  Paula Meleady
Journal:  Cytotechnology       Date:  2007-02-24       Impact factor: 2.058

4.  Using cell engineering and omic tools for the improvement of cell culture processes.

Authors:  Darrin Kuystermans; Britta Krampe; Halina Swiderek; Mohamed Al-Rubeai
Journal:  Cytotechnology       Date:  2007-02-24       Impact factor: 2.058

5.  Relationship between cell size, cell cycle and specific recombinant protein productivity.

Authors:  D R Lloyd; P Holmes; L P Jackson; A N Emery; M Al-Rubeai
Journal:  Cytotechnology       Date:  2000-10       Impact factor: 2.058

6.  Application of a reversible immortalization system for the generation of proliferation-controlled cell lines.

Authors:  Tobias May; Werner Lindenmaier; Dagmar Wirth; Peter P Mueller
Journal:  Cytotechnology       Date:  2005-11-30       Impact factor: 2.058

7.  MicroRNAs: recently discovered key regulators of proliferation and apoptosis in animal cells : Identification of miRNAs regulating growth and survival.

Authors:  Patrick Gammell
Journal:  Cytotechnology       Date:  2007-02-20       Impact factor: 2.058

8.  Tuning gene expression with synthetic upstream open reading frames.

Authors:  Joshua P Ferreira; K Wesley Overton; Clifford L Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-24       Impact factor: 11.205

Review 9.  Current state and recent advances in biopharmaceutical production in Escherichia coli, yeasts and mammalian cells.

Authors:  Aleš Berlec; Borut Strukelj
Journal:  J Ind Microbiol Biotechnol       Date:  2013-02-06       Impact factor: 3.346

10.  Epigenetic engineering of ribosomal RNA genes enhances protein production.

Authors:  Raffaella Santoro; Philipp Lienemann; Martin Fussenegger
Journal:  PLoS One       Date:  2009-08-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.